Biotech minnow Angle triumphs with cancer blood testing kit
Back to Topic
Click to Print
Useful Websites
Glossary Term Selection
This article is 6 years old.
Click here to view the latest articles for this topic.
By Julia Bradshaw
Biotech company Angle has scored a win after its blood testing technology was central in helping doctors discover a potentially ground-breaking treatment for cancer.
The Aim-listed firm’s device, called Parsortix, is able to catch tumour cells circulating in the blood through a simple blood test.
Now researchers at Basel University Hospital in Switzerland have shown that Parsortix can also harvest tumour cells that are attached to each other in clusters, called circulating tumour cell clusters, or CTC clusters. These are highly metastatic, meaning they spread the cancer easily, but research has been limited because until now it has not been possible to harvest them.
To read the rest of this article from the Telegraph click here
Want to see the rest of this article?
Would you like to see the rest of this article and all the other benefits that Issues Online can provide with?
- Useful related articles
- Video and multimedia references
- Statistical information and reference material
- Glossary of terms
- Key Facts and figures
- Related assignments
- Resource material and websites
